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Letter to the editorSeroprevalence of cytomegalovirus infection among
anpregnant women in Eastern Ir
Dear Editor,
Human cytomegalovirus (CMV) is the most common cause of
congenital infection, with morbidity and mortality at birth.1–5
Usually, there are no clinical symptoms for CMV during pri-
mary infection, reactivation, and re-infection with a different
CMV strain, but infected individuals may transmit the virus
via body ﬂuids such as saliva, blood, cervical secretion, semen,
1–4and urine. The risk of intrauterine infection largely depends
on the time of maternal infection during pregnancy – it is low-
est at the time of conception, and is increased in the third
trimester.4 Some studies concluded that CMV infection lead
to miscarriage and stillbirth.4,5
Table 1 – Distribution of CMV seroprevalence regarding the stud
Variables Total participants n (%) CM
CM
Mean age (years) 28.72± 5.45 28
Age (years)
<30 153 (63.7%) 101
≥ 30 87 (36.2%) 66
Education
Elementary 19 (7.9%) 14
High school 79 (32.9%) 57
University/College degree 80 (33.3%) 51
>University/College degree 62 (25.8%) 45
Residency
Urban area 176 (73.3%) 114
Rural area 64 (26.7%) 53
Previous abortion
No 187 (77.9%) 122
Yes 53 (22.1%) 45
Pregnancy
Primigravid 77 (32.1%) 50
Multiparous 163 (67.9%) 117
Proper hand washing practices
Rarely 4 (1.7%) 2
Sometimes 79 (32.9%) 66
Often 80 (33.3%) 67
Always 77 (32.1%) 32The need for diagnostic tests at all stages of gestation has
always been the subject of debate due to the insufﬁcient evi-
dence of congenital abnormalities in re-infection. Thus, the
CMV infection diagnostic test is still not considered part of
routine prenatal tests.4,5 Currently, no national screening test
for CMV infection is available at all stages of pregnancy in
Iran.
Considering the importance of intrauterine CMV infection
transmission and its complications, it is necessary to studyied variables.
V-IgG+
V-IgM-
n (%)
CMV-IgG-
CMV-IgM-
n (%)
p-value CMV-IgM+
n (%)
.04± 5.26 27.28± 5.90 p=0.326 23± 2.19
(68.7%) 46 (31.3%) p=0.242 6 (3.4%)
(75.59%) 21 (24.1%) .
(73.3%) 5 (26.3%) p=0.117 .
(75. %) 19 (25.0%) 3 (3.8%)
(64.6%) 28 (35.4%) 1 (1.3%)
(75.0%) 15 (25.0%) 2 (3.2%)
(67.1%) 56 (32.9%) p=0.017 6 (3.4%)
(82.8%) 11 (17.2%) .
(67.4%) 59 (32.6%) p=0.013 6 (3.2%)
(84.9%) 8 (15.1%) OR=2.72 .
(68.5%) 23 (31.5%) p=0.643 4 (5.2%)
(72.7%) 44 (27.3%) 2 (1.2%)
(50.0%) 2 (50.0%) p=0.000 .
(86.8%) 10 (13.2%) 5 (6.3%)
(84.8%) 12 (15.2%) 1 (1.3%)
(42.9%) 43 (57.3%) .
the prevalence of CMV infection in pregnancy with regional
interests. The aim of this study was to determine the sero-
prevalence of CMV infection in a pregnant population in
Eastern Iran. The effects of age, residency, abortion, parity,
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nd education on the seroprevalence of the infection have also
een investigated.
In this descriptive study, 240 serum samples were collected
rom pregnant women at the third trimester from February
o April, 2011, using the ELISA method, to measure CMV IgG
nd IgMmarkers. The IgG avidity test was used for all patients
howereCMV-IgM+ andCMV-IgG+ to distinguish betweenpri-
ary and recurrent CMV infection. All CMV-IgM+ of pregnant
omen were monitored until labor.
This study was approved by the Ethical Review Commit-
ee of the Islamic Azad University, Gonabad Branch, Gonabad,
ran.
In our study, the CMV seroprevalence rate was 72.1%.
mong the 240 tested women, 167 (69.6%) had had a previ-
us CMV infection and 67 (27.9%) had never been infected
ith CMV. The remaining six (2.5%) women were CMV-
gM+. In the latter group, four women (1.66%) had recurrent
MV infection (IgM+ and high IgG avidity) and two (0.84%)
omen had primary CMV infection (IgM+ and low IgG
vidity).
There was signiﬁcant correlation of history of abor-
ion, residence place, and personal hygiene status with IgG
eropositivity rate (Table 1). Two CMV-IgM+ subjects were
aced with preterm labor and low birth weight. Due to the
mall number of CMV-IgM+ pregnant women, we could not
raw any deﬁnitive conclusion about the consequences to
regnancy. Further studies should follow-up women with pri-
ary and recurrent CMV infection in the third trimester of
regnancy.
Failure to detect asymptomatic infected neonates, who are
t the risk of complications such as sensorineural hearing loss,
ision loss, and mental retardation, can have a negative effect
n the development of children.2,4 The application of a non-
nvasive serological assay to detect CMV infection would be
dvantageous for asymptomatic newborns, though it could
ot change the outcomes of pregnancy.onﬂict of interest
ll authors declare to have no conﬂict of interest.2;16(4):402–403 403
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